Skip to main content
. 2022 Mar 31;2022:9205908. doi: 10.1155/2022/9205908

Figure 1.

Figure 1

GN improves cardiac function and reduces myocardial fibrosis after TAC: (a) echocardiographic detection; (b) EF(%), FS(%), LVESV(μl), LVEDV(μl), E/A ratio, LVD-D(mm), LVD-S(mm), and myocardial fibrosis area (%); (c) hematoxylin-eosin staining; (d) Masson staining; (e) Sirius red staining. ∗p < 0.05.